References
National Comprehensive Cancer Network (NCCN). Clinical practice guidelines oncology—breast cancer (Version 3.2018). 2018 [January 28, 2018]; Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.
Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258–64.
Hieken TJ, Boughey JC, Jones KN, Shah SS, Glazebrook KN. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol. 2013;20(10):3199–204.
Boughey JC, Ballman KV, Hunt KK, et al. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the american college of surgeons oncology Group Z1071 Trial (Alliance). J Clin Oncol. 2015;33(30):3386–93.
Moo T-A, Jochelson MS, Zabor EC, et al. Is clinical exam of the axilla sufficient to select node-positive patients who downstage after NAC for SLNB? A comparison of the accuracy of clinical exam versus MRI. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07867-x.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Dr. Monica Morrow has received speaking honoraria from Genomic Health and Roche.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections is a brief invited commentary on the article, Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07867-x.
Rights and permissions
About this article
Cite this article
Moo, TA., Morrow, M. ASO Author Reflections: A Negative Axillary Clinical Exam Adequately Identifies Clinically Node-Positive Patients who Downstage After NAC and are Candidates for SLNB. Ann Surg Oncol 26, 4244–4245 (2019). https://doi.org/10.1245/s10434-019-07890-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07890-y